ReproCELL Incorporated
4978.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.63 | 0.04 | 0.31 | -0.10 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -96.10 | -46.62 | 118.77 | -260.90 |
| Quality | ||||
| ROIC | -2.91% | -3.35% | 0.55% | -0.35% |
| Gross Margin | 38.49% | 40.73% | 58.14% | 55.08% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 1.41% | -0.10% | 0.28% | -2.91% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 16.10 | 9.46 | -30.33 | 165.22 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.01 | 1.03 | 1.41 | 1.00 |
| Cash Conversion Cycle | 105.31 | 108.41 | 78.77 | 110.53 |